| Patent | Date |
|---|
Chemical Compounds
App 20210238162 - CADILLA; Rodolfo ; et al. | 2021-08-05 |
Naphthyridines As Integrin Antagonists
App 20210206758 - ANDERSON; Niall Andrew ; et al. | 2021-07-08 |
1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors
Grant 11,053,234 - Deaton , et al. July 6, 2 | 2021-07-06 |
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
Grant 10,513,517 - Anderson , et al. Dec | 2019-12-24 |
Naphthyridines as integrin antagonists
Grant 10,487,080 - Anderson , et al. Nov | 2019-11-26 |
NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.
App 20190275016 - ANDERSON; Niall Andrew ; et al. | 2019-09-12 |
1,3 Di-substituted Cyclobutane Or Azetidine Derivatives As Hematopoietic Prostaglandin D Synthase Inhibitors
App 20190241554 - DEATON; David Norman ; et al. | 2019-08-08 |
Compounds .alpha..sub.v.beta..sub.6 integrin antagonists
Grant 10,342,783 - Anderson , et al. July 9, 2 | 2019-07-09 |
Naphthyridines As Integrin Antagonists
App 20190112306 - ANDERSON; Niall Andrew ; et al. | 2019-04-18 |
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases
App 20190048005 - ANDERSON; Niall Andrew ; et al. | 2019-02-14 |
Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases
Grant 10,144,733 - Anderson , et al. De | 2018-12-04 |
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
App 20180271845 - Anderson; Niall Andrew ; et al. | 2018-09-27 |
Compounds alpha v beta 6 integrin antagonists
Grant 10,004,724 - Anderson , et al. June 26, 2 | 2018-06-26 |
Compounds .alpha..sub.v.beta..sub.6 integrin antagonists
Grant 10,000,489 - Anderson , et al. June 19, 2 | 2018-06-19 |
Compounds .alpha..sub.v .beta..sub.6 integrin antagonists
Grant 9,956,209 - Anderson , et al. May 1, 2 | 2018-05-01 |
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
App 20170298063 - Anderson; Niall Andrew ; et al. | 2017-10-19 |
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
App 20170290817 - Anderson; Niall Andrew ; et al. | 2017-10-12 |
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
App 20170290818 - ANDERSON; Niall Andrew ; et al. | 2017-10-12 |
Naphthyridine Derivatives As Alpha V Beta 6 Integrin Antagonists For The Treatment Of E.g. Fibrotic Diseases
App 20170291899 - ANDERSON; Niall Andrew ; et al. | 2017-10-12 |
Substituted Quinoline Derivatives As H1 Receptor Antagonists
App 20110281909 - Gore; Paul Martin ; et al. | 2011-11-17 |
Compounds
Grant 7,884,114 - Gore , et al. February 8, 2 | 2011-02-08 |
Quinoline Derivatives Used To Treat Inflammatory And Allergic Diseases
App 20100222349 - Gore; Paul Martin ; et al. | 2010-09-02 |
Substituted Piperazines, (1,4) Diazepines, And 2,5-diazabicyclo (2.2.1) Heptanes As Histamine H1 And/or H3 Antagonists Or Histamine H3 Reverse Antagonists
App 20100075953 - Ancliff; Rachael ; et al. | 2010-03-25 |
Compounds
App 20090270355 - Gore; Paul Martin ; et al. | 2009-10-29 |
Histamine Receptor Antagonists Comprising an Azepin Core
App 20090181950 - Ancliff; Rachael Ann ; et al. | 2009-07-16 |
2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
App 20090105225 - Gore; Paul Martin ; et al. | 2009-04-23 |
Compounds
App 20080039444 - GORE; Paul Martin ; et al. | 2008-02-14 |
Compounds
App 20060293298 - Bamford; Mark James ; et al. | 2006-12-28 |
Compounds
App 20060019964 - Ancliff; Ranchael Ann ; et al. | 2006-01-26 |
| 